Sharps Technology Completes Private Funding Round on August 25, 2025

According to media reports, Sharps Technology completed a Private funding round on August 25, 2025. Investors in this round included Pantera Capital, ParaFi Capital, Borderless Capital, CoinFund, Arrington Capital, Primitive Ventures, Hypersphere Ventures, FalconX, RockawayX, and Quantstamp.Sharps Technology is a Nasdaq-listed medical device company (ticker: STSS) specializing in the research, development, and production of innovative safety syringes. The company’s core mission is to reduce the risk of disease transmission from needlestick injuries through its technology, protecting healthcare workers, patients, and the public, while improving the accuracy and efficiency of drug delivery.Notably, according to recent updates, Sharps Technology expanded the size of its funding round to USD 1 billion on August 29, 2025, and initiated a digital asset treasury strategy. The company announced the establishment of a SOL treasury, with holdings exceeding 2 million SOL tokens as of September 2, 2025. In addition, Sharps Technology completed over USD 400 million in PIPE (Private Investment in Public Equity) financing to create the SOL treasury, reflecting strong investor confidence in the company’s strategic direction.This series of funding activities not only highlights Sharps Technology’s innovative capabilities in the traditional medical device sector but also demonstrates its forward-thinking approach to digital asset management, laying a solid foundation for the company’s sustainable growth.